Skip to main content
Log in

Crystal structure and conformation of Tilorone monohydrate [2,7-{bis1-oxo-4-(1-piperidinyl)butyl}-9H-fluoren-9-one] monohydrate: an antiviral agent and an interferon inducer

  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

Tilorone is an orally active pharmacological agent that protects mice against infections with RNA and DNA viruses. It is also the only known small molecule that is an interferon inducer. It has anti-tumor and anti-inflammatory properties and was shown to interact and influence the immune mechanisms in human and animals. Structure-function studies of Tilorone and its several analogs have been undertaken in our laboratories with an objective to correlate the structural features with the immuno-suppressive activity. Crystals of the title compound are triclinic, space group \(P\bar 1 \), with the following crystallographic parameters: a = 7.068(2), b = 9.030(3), c = 23.635(3) Å, α = 103.91(2), β = 108.49(2), γ = 93.84(4)°, V = 1371.9 Å3, ρobs = 1.17 Mg/m3, ρcalc = 1.168 Mg/m3 and Z = 2. The structure was solved with CAD-4 data, using SHELX-86 program and refined to a final R value of 0.063. The oxobutyl groups are in an extended zig-zag conformation and are co-planar with the central fluorenone chromophore. The two terminal piperidine rings are in the preferred chair conformation. The crystal structure lends support to the intercalative mechanism of action for Tilorone. We hypothesize that the stereochemistry and molecular geometry of these drugs and/or their active metabolites affect both the receptor interaction and the mode of immunomodulation. Comparison of the biological effects of the various tilorone analogs should allow us to obtain some more insight into their structure-function correlations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Regelson, W. Pharmac. Sci. 1981,15, 1-44.

    Google Scholar 

  2. Andrews, E.R.; Fleming, R.W.; Grisar, J.M.; Kihm, J.C.; Weastrip, D.L.; Mayer, G.D. J. Med. Chem. 1974,17, 882-886.

    Google Scholar 

  3. Albrecht, W.L.; Fleming, R.W.; Horgan, S.W.; Kihm, J.C.; Mayer, G.D. J. Med. Chem. 1974,17, 886-889.

    Google Scholar 

  4. Adamson, R.H. J. Natl. Cancer Inst. 1971,46, 431-434.

    Google Scholar 

  5. Munson, A.E.; Munson, J.A.; Regelson, W.; Wampler, G.L. Cancer Res. 1972,32, 1397-1403.

    Google Scholar 

  6. Chandra, P.; Zunino, F.; Zaccara, A.; Wacker, A.; Götr, A. FEBS Lett. 1972,23, 145-148.

    Google Scholar 

  7. Chandra, P.; Zunino, F.; Gaur, V.P.; Zaccara, A.; Wattersdorf, M.; Luoni, G.; Götr, A. FEBS Lett. 1972,28, 5-9.

    Google Scholar 

  8. Chandra, P.; Zunino, R.; Götr, A. FEBSLett. 1972,22, 161-164.

    Google Scholar 

  9. Mobraaten, L.E.; Mayer, E.D.; Maeyer-Grignard, J.D. Transplantation 1973,16, 415-420.

    Google Scholar 

  10. Wildstein, A.; Stevens, L.E.; Hashim, G. Transplantation 1976,21, 129-132.

    Google Scholar 

  11. Hoffmann, P.F.; Ritter, H.W.; Krueger, R.F. In Advanced in Antimicrobial and Antineoplastic Chemotherapy; Hejzlar, M.; Semonsky, M.; Mosak, M., Eds.; Urban and Schwarbenberg: Munich, Germany, 1970; pp 217-228.

    Google Scholar 

  12. Diamantstein, T. Immunology 1973,24, 771-775.

    Google Scholar 

  13. Megel, H.; Raychaudhuri, A.; Goldstein, S.; Kinsolving, C.R.; Schemano, I.; Michael, J.G. Proc. Soc. Exp. Biol. Med. 1974,145, 513-518.

    Google Scholar 

  14. Srikrishnan, T.; Dasari, K.B.; Albini, B. Acta Crystallogr. 1993,A49, 130.

    Google Scholar 

  15. Srikrishnan, T. Anti-Cancer Drug Design 1990,5, 213-220.

    Google Scholar 

  16. Rooth, Walter.; Srikrishnan, T. J. Chem. Cryst. 1999 (in press).

  17. Enraf-Nonius Structure Determination Package; 1979,Enraf-Nonius: Delft, Netherlands.

  18. Germain, G., Main, P.; Woolfson, M.M. (197) Acta Crystallogr. A27, 368-371.

  19. Johnson, C.K. Report ORNL-3794; Oak Ridge National Laboratory: Tennessee, 1965.

    Google Scholar 

  20. Chen, K-X.; Gresh, N.; Pullman, B. Nuc. Acid Res. 1988,16, 3061-3073.

    Google Scholar 

  21. Sturm, J.; Sehreicher, L.; Daune, M. Biopolymers 1981,820, 767-785.

    Google Scholar 

  22. Sturm, J. Biopolymers 1982,21, 1189-1206.

    Google Scholar 

  23. Chandra, P.; Wottersdorf, M. FEBS Lett. 1974,41, 169-173.

    Google Scholar 

  24. Wright, R.G.; Wakelin, L.P.G.; Fieldes, A.; Acheson, R.M.; Waring, M.J. Biochemistry 1980,19, 5825-5836.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dasari, K.B., Srikrishnan, T. Crystal structure and conformation of Tilorone monohydrate [2,7-{bis1-oxo-4-(1-piperidinyl)butyl}-9H-fluoren-9-one] monohydrate: an antiviral agent and an interferon inducer. Journal of Chemical Crystallography 30, 269–273 (2000). https://doi.org/10.1023/A:1009551308395

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009551308395

Navigation